Clinical Trials Browser

Mesothelioma, Malignant, Anxiety Disorders, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Depression, Esophageal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT01231347 2024-07-16

GAMMA

Phase 3 Completed

800 enrolled 11 charts

Gastrointestinal

Endocrine Gland Neoplasms, Jaundice, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT01827553 2024-04-11

CONKO-007

Phase 3 Completed

830 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02395016 2024-04-04

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Phase 3 Completed

90 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02539537 2024-01-09

NEOPAN

Phase 3 Completed

171 enrolled

Gastrointestinal

Carcinoma, Pancreatic Neoplasms

NCT02993731 2023-11-15

CanStem111P

Phase 3 Completed

1,134 enrolled 18 charts

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT02184195 2023-09-13

POLO

Phase 3 Completed

154 enrolled 20 charts 1 FDA

Gastrointestinal

Pancreatic Neoplasms

NCT00057876 2023-07-05

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

Phase 3 Completed

74 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01964430 2023-06-28

apact

Phase 3 Completed

866 enrolled 21 charts

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms by Site, Pancreatic Diseases, Pancreatic Neoplasms

NCT03126435 2023-05-06

EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX

Phase 3 Completed

218 enrolled 19 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02853474 2023-04-26

EPIC-1511

Phase 3 Completed

480 enrolled

Gastrointestinal

Bile Duct Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT02948309 2023-01-13

MISTRAL

Phase 3 Completed

290 enrolled

Gastrointestinal

Pancreatic Neoplasms, Recurrence

NCT01926197 2022-10-28

Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

Phase 3 Completed

27 enrolled 15 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03766295 2020-12-08

Masitinib Plus Gemcitabine in Pancreatic Cancer

Phase 3 Completed

377 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02340728 2020-10-22

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies

Phase 3 Completed

24 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02923921 2020-10-19

Sequoia

Phase 3 Completed

567 enrolled 17 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01072981 2020-05-28

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Phase 3 Completed

722 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02043288 2020-04-15

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Phase 3 Completed

310 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00016380 2020-04-03

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Phase 3 Completed

211 enrolled

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Nausea, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Seminoma

NCT00026338 2020-04-02

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Phase 3 Completed

569 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01438476 2020-02-12

Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas

Phase 3 Completed

178 enrolled 9 charts

Gastrointestinal

Agnosia, Liver Neoplasms, Pancreatic Neoplasms

NCT00844649 2019-11-25

Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas

Phase 3 Completed

861 enrolled 19 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00789633 2018-12-17

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

Phase 3 Completed

353 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00040183 2018-01-10

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Phase 3 Completed

569 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01936467 2017-04-13

Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions

Phase 3 Completed

121 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00312013 2017-03-23

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Phase 3 Completed

503 enrolled

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Prostatic Neoplasms, Venous Thrombosis

NCT00003049 2016-12-22

Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas

Phase 3 Completed

100 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02988635 2016-12-09

Early Palliative Care on Quality of Life of Advanced Cancer Patients

Phase 3 Completed

281 enrolled

GastrointestinalThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Stomach Neoplasms

NCT01360853 2016-08-04

ONTRAC

Phase 3 Completed

160 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01494506 2016-06-17

NAPOLI-1

Phase 3 Completed

417 enrolled 20 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00417209 2016-06-03

PAPRIKA

Phase 3 Completed

408 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00416507 2016-05-30

Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Phase 3 Completed

190 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00994110 2016-02-01

Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess

Phase 3 Completed

439 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00634725 2015-12-11

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Phase 3 Completed

820 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00075686 2015-11-17

S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

Phase 3 Completed

766 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01521702 2015-03-20

NEOPAC

Phase 3 Completed

2 enrolled

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT01731821 2014-12-04

Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy

Phase 3 Completed

308 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis, Chronic

NCT01121848 2014-10-27

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Phase 3 Completed

108 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01214720 2014-08-13

A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer

Phase 3 Completed

607 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00679913 2014-06-06

Standardization of Surgery on the Pancreatic Cancer

Phase 3 Completed

244 enrolled 6 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01479803 2014-04-23

PICORE

Phase 3 Completed

80 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

RECITE

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer

MAESTRO

PREDICT

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

PANasta

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

GAMMA

CONKO-007

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

NEOPAN

CanStem111P

POLO

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

apact

EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX

EPIC-1511

MISTRAL

Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

Masitinib Plus Gemcitabine in Pancreatic Cancer

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies

Sequoia

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas

Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas

Early Palliative Care on Quality of Life of Advanced Cancer Patients

ONTRAC

NAPOLI-1

PAPRIKA

Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

NEOPAC

Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer

Standardization of Surgery on the Pancreatic Cancer

PICORE